Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Study Population

NG Naama Golan
SA Shai Ashkenazi
RD Rotem Davidovich
AL Alina Levinsky
AC Adina Bar Chaim
RH Ramzia Abu Hamad
OR Omer Raveh
SY Shai Yitzhaki
GL Gilat Livni
ask Ask a question
Favorite

The study was conducted in the Emergency and Pediatric Departments at Schneider Children’s Medical Center between May 20, 2021, and August 31, 2021. Infants born to mothers who had been vaccinated with the BNT162b2 COVID-19 vaccine during pregnancy were eligible to participate. Following informed consent, residual sera from the infants’ blood samples that were taken as part of medical evaluations were collected and stored. Mothers who escorted their infants during the visits were offered to participate as well; following consent, blood was drawn from the mothers and examined for the study. The study was approved by the Committee for Human Studies of the Medical Center.

Copyright and License information:  ©2022 The Author(s) 2022. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A